Clinical impact of using [ ¹⁸ F]AlF-NOTA-octreotide PET/CT instead of [ ⁶⁸ Ga]Ga-DOTA-SSA PET/CT: Secondary endpoint analysis of a multicenter, prospective trial.

Autor: Leupe H; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium., Pauwels E; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium., Vandamme T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.; Department of Oncology, Antwerp University Hospital & NETwerk Antwerpen-Waasland CoE, Edegem, Belgium., Van den Broeck B; Nuclear Medicine, Ghent University Hospital, Ghent, Belgium., Lybaert W; Department of Oncology, Antwerp University Hospital & NETwerk Antwerpen-Waasland CoE, Edegem, Belgium., Dekervel J; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Van Herpe F; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Jaekers J; Department of Visceral Surgery, University Hospitals Leuven, Leuven, Belgium., Cleeren F; Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium., Hofland J; Department of Internal Medicine, Section of Endocrinology, ENETS Centre of Excellence Rotterdam, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Brouwers A; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Koole M; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium., Bormans G; Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium., Van Cutsem E; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Geboes K; Digestive Oncology, Department of Gastroenterology, Ghent University Hospital, Ghent, Belgium., Laenen A; Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Belgium., Verslype C; Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Stroobants S; Nuclear Medicine, Antwerp University Hospital & Molecular Imaging and radiology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium., Deroose CM; Department of Imaging and Pathology, Nuclear Medicine, University Hospitals Leuven & Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium.

Publikováno v: Journal of neuroendocrinology [J Neuroendocrinol] 2024 Aug; Vol. 36 (8), pp. e13420. Date of Electronic Publication: 2024 Jun 04.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[ ¹⁸ F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [ ¹²³ I] MIBG in neural crest tumour patients.

Autor: Pauwels E; Nuclear Medicine, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Celen S; Radiopharmaceutical research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium., Baete K; Nuclear Medicine, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Koole M; Nuclear Medicine, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Bechter O; General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Bex M; Endocrinology, University Hospitals Leuven, Leuven, Belgium., Renard M; Paediatric Oncology, University Hospitals Leuven, Leuven, Belgium., Clement PM; General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Jentjens S; Nuclear Medicine, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Serdons K; Nuclear Medicine, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Van Laere K; Nuclear Medicine, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Bormans G; Radiopharmaceutical research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, Belgium., Deroose CM; Nuclear Medicine, University Hospitals Leuven, Campus Gasthuisberg, Herestraat 49, BE-3000, Leuven, Belgium. christophe.deroose@uzleuven.be.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium. christophe.deroose@uzleuven.be.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Mar; Vol. 50 (4), pp. 1134-1145. Date of Electronic Publication: 2022 Nov 26.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.